Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3449057)

Published in Int J Colorectal Dis on March 21, 2012

Authors

K Homayounfar1, A Bleckmann, L C Conradi, T Sprenger, T Beissbarth, T Lorf, M Niessner, C O Sahlmann, J Meller, H Becker, T Liersch, B M Ghadimi

Author Affiliations

1: Department of General and Visceral Surgery, University Medical Center, Georg August University Göttingen, Robert-Koch-Strasse 40, Göttingen, Germany. khomayounfar@chirurgie-goettingen.de

Articles cited by this

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet (2008) 9.92

Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer (1996) 7.38

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol (2009) 5.57

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg (2008) 4.86

Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol (2006) 4.42

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol (2008) 4.37

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol (2008) 3.49

The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg (2005) 3.46

Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 2.96

High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol (2011) 2.28

A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg (2004) 2.20

[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03

Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology (2001) 1.91

Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg (2008) 1.85

Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer (2007) 1.84

[Update S3-guideline "colorectal cancer" 2008]. Z Gastroenterol (2008) 1.81

Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg (2010) 1.73

Patterns of referral and resection among patients with liver-only metastatic colorectal cancer (MCRC). Ann Surg Oncol (2010) 1.61

Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score. Ann Surg Oncol (2007) 1.60

OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol (2005) 1.52

Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg (2008) 1.52

Remnant liver volume to body weight ratio > or =0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg (2006) 1.48

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial. Br J Cancer (2010) 1.38

Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases. Ann Surg Oncol (2010) 1.27

Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg (2007) 1.25

Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol (2006) 1.17

Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy. Ann Surg Oncol (2008) 1.08

Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group. Ann Surg Oncol (2007) 1.02

Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol (2008) 0.98

Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases. J Gastrointest Surg (2009) 0.87

Is surgical resection justified for stage IV colorectal cancer patients having bilobar hepatic metastases?--an analysis of survival of 77 patients undergoing hepatectomy. J Surg Oncol (2010) 0.85

Multimodal treatment options for bilobar colorectal liver metastases. Langenbecks Arch Surg (2010) 0.80

Articles by these authors

fw2.2: a quantitative trait locus key to the evolution of tomato fruit size. Science (2000) 7.91

The European experience with laparoscopic cholecystectomy. Am J Surg (1991) 6.24

Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain (2006) 5.55

Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res (1999) 3.06

The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res (2001) 2.51

Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg (1992) 2.38

Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg (1995) 2.36

The motor vehicle accident in family practice. Can Fam Physician (1988) 2.08

Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging (2003) 1.89

Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer. Eur J Surg Oncol (2000) 1.73

Control of macromolecular synthesis in proliferating and resting Syrian hamster cells in monolayer culture. I. Ribosome function. J Cell Physiol (1971) 1.71

Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours. Br J Surg (2003) 1.66

Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes. J Exp Med (1989) 1.60

[Computer tomography in the diagnosis of epilepsy (author's transl)]. Nervenarzt (1977) 1.53

Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomised controlled multicentre trial. Thorax (2005) 1.51

A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation (2001) 1.51

Breast reconstruction using an inflatable breast implant with detachable reservoir. Plast Reconstr Surg (1984) 1.50

GeneNest: automated generation and visualization of gene indices. Trends Genet (2000) 1.50

Preoperative local MRI-staging of patients with a suspected pancreatic mass. Eur Radiol (2001) 1.49

Laparoscopic fundoplication. Surg Endosc (2001) 1.47

Radiation therapy and tamoxifen after breast-conserving surgery: updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence. Eur J Cancer (2010) 1.46

Role of the thymus in transplantation tolerance in miniature swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I-mismatched renal allografts. J Exp Med (1997) 1.44

Three-dimensional endoluminal ultrasound: a new method for the evaluation of gastrointestinal tumors. Abdom Imaging (1999) 1.42

Left ventricular myxoma: echocardiographic diagnosis and review of the literature. Am J Med (1977) 1.42

[The carcinogenic potential of biomaterials in hernia surgery]. Chirurg (2002) 1.41

[Recommendations for diagnosis, therapy and long-term management of patients with sleep apnea]. Med Klin (Munich) (1991) 1.40

Comparing propofol versus sevoflurane anesthesia for epileptogenic focus detection during positron emission tomography in pediatric patients. Minerva Anestesiol (2013) 1.40

The effect of betadine on silicone implants. Plast Reconstr Surg (2000) 1.39

Jumping translocations are common in solid tumor cell lines and result in recurrent fusions of whole chromosome arms. Genes Chromosomes Cancer (2001) 1.38

Histopathological features of liver disease in alpha 1-antitrypsin deficiency. Acta Paediatr Suppl (1994) 1.38

Subdermal liposuction to enhance skin contraction: a preliminary report. Ann Plast Surg (1992) 1.38

Sneddon's syndrome: clinical course and outcome. J Neurol (1989) 1.37

Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Circulation (1979) 1.35

The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbecks Arch Surg (2009) 1.33

The role of triterpenoids in the topical anti-inflammatory activity of Calendula officinalis flowers. Planta Med (1994) 1.30

Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis (2003) 1.30

Surgical cure for early rectal carcinoma and large adenoma: transanal endoscopic microsurgery (using ultrasound or electrosurgery) compared to conventional local and radical resection. Int J Colorectal Dis (2002) 1.27

Archaeal aminoacyl-tRNA synthesis: diversity replaces dogma. Genetics (1999) 1.25

Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column. Transplantation (1998) 1.23

CT fogging effect with ischemic cerebral infarcts. Neuroradiology (1979) 1.21

The effect of hypothalamic luteinizing hormone releasing hormone (LH-RH) on plasma gonadotrophin levels in normal subjects. Clin Endocrinol (Oxf) (1974) 1.20

β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis (2010) 1.20

Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology (1991) 1.19

UltraCision or high-frequency knife in transanal endoscopic microsurgery (TEM)? Advantages of a new procedure. Surg Endosc (2001) 1.19

Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry (2004) 1.18

Prevention of capsular contracture. Plast Reconstr Surg (1999) 1.17

[Total aplasia of the diaphragm with hypoplasia of the lungs (author's transl)]. Klin Padiatr (1978) 1.17

Sarco/endoplasmic reticulum calcium ATPase-2 expression is regulated by ATF6 during the endoplasmic reticulum stress response: intracellular signaling of calcium stress in a cardiac myocyte model system. J Biol Chem (2001) 1.17

Diagnostic value of the fast-FLAIR sequence in MR imaging of intracranial tumors. Eur Radiol (2000) 1.17

Septal perforator compression (narrowing) in idiopathic hypertrophic subaortic stenosis. Am J Cardiol (1977) 1.15

The role of nuclear medicine in infection and inflammation. Lancet Infect Dis (2001) 1.15

The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment. Eur J Clin Pharmacol (1988) 1.14

Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients. J Clin Oncol (1991) 1.14

3D visualisation of the middle ear and adjacent structures using reconstructed multi-slice CT datasets, correlating 3D images and virtual endoscopy to the 2D cross-sectional images. Neuroradiology (2002) 1.12

Predicting postoperative morbidity by clinical assessment. Br J Surg (2005) 1.12

Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus (2004) 1.11

The treatment of gynecomastia without sharp excision. Ann Plast Surg (1990) 1.10

Transplancental cardioversion of intrauterine supraventricular tachycardia with digitalis. Lancet (1980) 1.10

Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis (2004) 1.09

Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines. Genes Chromosomes Cancer (2000) 1.09

Mesh penetration of the sigmoid colon following a transabdominal preperitoneal hernia repair. Surg Endosc (2002) 1.09

Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol (2001) 1.08

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study). Ann Oncol (2014) 1.07

Control of macromolecular synthesis in proliferating and resting Syrian hamster cells in monolayer culture. II. Ribosome complement in resting and early G1 cells. J Cell Physiol (1971) 1.07

Update of current immunosuppressive drugs used in clinical organ transplantation. Transpl Int (1998) 1.07

Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment. Int J Clin Pract (2006) 1.07

Non-Q-wave infarction and ostial left coronary obstruction due to giant Lambl's excrescences of the aortic valve. Circulation (1999) 1.07

Outcome of palliative urinary diversion in the treatment of advanced malignancies. Cancer (1999) 1.07

Prostaglandin E1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology (1989) 1.07

Rat hepatic sinusoidal endothelial cells in monolayer culture. Biochemical and ultrastructural characteristics. J Hepatol (1988) 1.07

Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses. Biochim Biophys Acta (1992) 1.06

Towards outcome-based programme evaluation: using student comparative self-assessments to determine teaching effectiveness. Med Teach (2011) 1.06

Critical importance of ensuring cardioplegic delivery with coronary stenoses. J Thorac Cardiovasc Surg (1981) 1.06

[A medium for th diagnosis of vaginal candidiasis]. Mykosen (1971) 1.05

Discrimination of direct and indirect interactions in a network of regulatory effects. J Comput Biol (2007) 1.05

Cyclosporin in infiltrative eye disease. Lancet (1984) 1.05

Growth, terpenoid production and antibacterial activity of an in vitro culture of the liverwort Fossombronia pusilla. Planta Med (1990) 1.04

Standardization of carotid ultrasound: a hemodynamic method to normalize for interindividual and interequipment variability. Stroke (1999) 1.03

A dual-specific Glu-tRNA(Gln) and Asp-tRNA(Asn) amidotransferase is involved in decoding glutamine and asparagine codons in Acidithiobacillus ferrooxidans. FEBS Lett (2001) 1.03

Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure. N Engl J Med (1982) 1.02

Evaluation of surface and volume rendering in 3D-CT of facial fractures. Dentomaxillofac Radiol (2006) 1.02

Sesquiterpenoids and diterpenoids from the Chilean liverwort Lepicolea ochroleuca. Phytochemistry (2000) 1.02

18F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med Mol Imaging (2002) 1.02

Production of an antiviral factor by murine spleen cells after treatment with Corynebacterium parvum. Cell Immunol (1977) 1.02

Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. Circulation (1983) 1.02

Prognosis factors in incisional hernia surgery: 25 years of experience. Hernia (2004) 1.01

African-American women's perceptions of mammography screening. J Natl Black Nurses Assoc (2001) 1.01

Longitudinal studies of plasma aldosterone, corticosterone, deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone determined simultaneously in mother and child at birth and during the early neonatal period. I. Spontaneous delivery. J Clin Endocrinol Metab (1978) 1.01

Targeting NCA-95 and other granulocyte antigens and receptors with radiolabeled monoclonal antibodies (Mabs). Q J Nucl Med Mol Imaging (2010) 1.01

Characterization of a monoclonal anti-porcine CD3 antibody. Xenotransplantation (1999) 1.01

Reliability of peroneal reaction time measurements. Clin Biomech (Bristol, Avon) (2000) 1.01

Survivin as a prognostic/predictive marker and molecular target in cancer therapy. Curr Med Chem (2012) 1.00